LLY vs. TSM: Eli Lilly vs. TSMC Stock Comparison

Company Profile

Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas TSMC (TSM) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Eli Lilly (LLY) trades as ordinary local shares, while TSMC (TSM) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

TSMC (TSM) has an aggressive beta of 1.38, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.50 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Eli Lilly (LLY) at 102.29% and TSMC (TSM) at 39.97% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

Eli Lilly (LLY) at 33.53% keeps the most of each sales dollar — above its industry’s net margin range — and TSMC (TSM) at 49.92% also retains a top-quartile share.

TSMC (TSM) at 60.34% shows unusually strong operating efficiency — above its industry’s operating margin range — and Eli Lilly (LLY) at 54.22% also operates in the top quartile.

Profitability Metrics

Growth

TSMC (TSM) at 31.61% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for TSM.

Both Eli Lilly (LLY) at 95.99% and TSMC (TSM) at 46.41% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Growth Metrics

Financial Strength

TSMC (TSM) at 2.46 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.36 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.

TSMC (TSM) at 0.15 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.62 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Both Eli Lilly (LLY) at 0.54% and TSMC (TSM) at 2.87% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both pay out more than their industries’ typical bands, and LLY more so: TSMC (TSM) at 27.93% sits above the band, while Eli Lilly (LLY) at 21.69% exceeds every peer in its group.

Dividend Metrics

Valuation

TSMC (TSM) at 36.91 sits in the cheaper P/E ratio quartile, while Eli Lilly (LLY) at 40.00 is closer to its industry’s usual earnings multiple — a discount for TSM, though growth and earnings durability still matter.

TSMC (TSM) at 0.49 sits in the cheaper P/S ratio quartile while Eli Lilly (LLY) at 13.27 prices around its industry’s middle — TSM costs less per dollar of sales, though read it alongside growth and margins.

Measured against book value, both Eli Lilly (LLY) at 33.96 and TSMC (TSM) at 87.60 look expensive — each P/B ratio sits above its industry’s benchmark range.

Valuation Metrics